UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Korea’s 30th novel drug K-Cab to get insurance benefit from March
by Lee Hye-seon
2019-02-27 16:47
Korea’s drug exports hit record high in 2018, industry group says
by Kim Yun-mi
2019-02-27 13:08
GC unveils P1 results for hepatitis B treatment
by Lee Han-soo
2019-02-26 16:07
‘Heat-not-burn cigarettes as risky as traditional ones’
by Kim Yun-mi
2019-02-26 15:45
Yuclid’s antiplatelet effect confirmed in patients undergoing carotid artery stenting
by Lee Hye-seon
2019-02-26 14:36
라인
‘Hardy kiwi extract can treat psoriasis’
by Lee Han-soo
2019-02-26 14:34
Daewon licenses in Tium Bio’s endometriosis drug candidate
by Lee Han-soo
2019-02-26 13:58
CrystalGenomics’ US partner applies for P1 trial for leukemia treatment
by Lee Han-soo
2019-02-26 11:29
Regulator OKs GC’s P3 trial of BCG vaccine
by Lee Han-soo
2019-02-25 14:07
Lung cancer 2nd treatment Alunbrig likely to get insurance coverage
by Kim Yun-mi
2019-02-25 14:06
라인
Regulator OKs Bukwang’s anticancer treatment
by Lee Han-soo
2019-02-22 15:29
Will first-ever treatment for nonalcoholic fatty liver arrive?
by Kim Yun-mi
2019-02-22 15:29
Hugel hits record-high quarterly sales
by Lee Han-soo
2019-02-22 13:30
Huons posts record-high sales in 2018
by Lee Han-soo
2019-02-21 17:17
Mediforum verifies safety, efficacy of dementia treatment candidate
by Lee Han-soo
2019-02-21 15:13
라인
DPP-4 inhibitors raise bullous pemphigoid risk in diabetic patients: study
by Kim Yun-mi
2019-02-21 15:13
Xtandi adds indication for non-metastatic castration-resistant prostate cancer
by Kim Yun-mi
2019-02-21 15:10
SCM, Allele to develop diabetes treatment
by Lee Han-soo
2019-02-21 14:57
Pfizer’s patent barrier foils Korea’s 1st pneumococcal conjugate vaccine
by Lee Han-soo
2019-02-20 16:18
FDA rejects Medytox’s ‘citizen petition’ against Daewoong
by Lee Han-soo
2019-02-20 14:37
-
이전
51
52
53
54
55
56
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top